Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03617913
Title Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Recruitment Completed
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic

bladder urothelial carcinoma


Avelumab + Cisplatin + Fluorouracil + Mitomycin C

Age Groups:
Covered Countries USA

No variant requirements are available.